IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aerie Pharmaceuticals Inc COM

CUSIP: 00771V107 | 1 institutional holders

Quarters

Q2 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2020

Endurance Wealth Management, Inc.200
0.0% of portfolio›$3
StyleTurnoverLocationFiled
Endurance Wealth Management, Inc.
200$30.0%N/AN/AProvidence, RI2020-07-14